Salivary gland tumours in Iceland 1986-2015: a nationwide epidemiological analysis over a 30-year time period.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationAegisdottir AL, Tryggvason G, Jonsdottir AM, Jonasson JG. Salivary gland tumours in Iceland 1986-2015: a nationwide epidemiological analysis over a 30-year time period. APMIS. 2020 Oct 16. doi: 10.1111/apm.13090.
AbstractSalivary gland tumours (SGT) are a vast and heterogenous group of neoplasms. There is a relative lack of comprehensive nationwide epidemiological studies on the subject. The aim of this nationwide analysis was to gain insight into epidemiological traits, such as site, incidence and histological subtypes of SGT in general. Patients diagnosed with a primary SGT between 1986 and 2015 were identified from The Icelandic Cancer Registry and registries from all pathology departments in Iceland. Information on age, sex, tumour location and histology was retrieved from pathology reports. A total of 687 patients were diagnosed with a SGT, 609 (89%) were benign and 78 (11%) malignant. 9% of parotid gland tumours, 22% of submandibular gland tumours and 26% of minor SGT were malignant. The most common malignant tumours were mucoepidermoid carcinoma, acinic cell carcinoma and adenoid cystic carcinoma. The incidence of benign SGT was 4.9 per 100 000 among men and 7.0 per 100 000 among women. The incidence of malignant tumours was 0.59 per 100 000 for men and 0.79 per 100 000 for women. The proportion of malignant SGT is lower than most often reported. Only 10% of parotid gland tumours, 20% of submandibular gland tumours and 25% of minor salivary gland tumours are malignant. Keywords: Salivary gland; epidemiology; histology; oncology; tumour.
DescriptionTo access publisher's full text version of this article click on the hyperlink below
Rights© 2020 APMIS. Published by John Wiley & Sons Ltd.
- Salivary gland carcinoma in Denmark 1990-2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA).
- Authors: Bjørndal K, Krogdahl A, Therkildsen MH, Overgaard J, Johansen J, Kristensen CA, Homøe P, Sørensen CH, Andersen E, Bundgaard T, Primdahl H, Lambertsen K, Andersen LJ, Godballe C
- Issue date: 2011 Jul
- Salivary gland carcinoma in Shanghai (2003-2012): an epidemiological study of incidence, site and pathology.
- Authors: Fu JY, Wu CX, Shen SK, Zheng Y, Zhang CP, Zhang ZY
- Issue date: 2019 Apr 11
- Retrospective analysis of intra-oral salivary gland tumours in Ibadan, Nigeria.
- Authors: Adeyemi BF, Ogun GO, Akang EE
- Issue date: 2010 Mar-Apr
- Salivary gland tumors: a single institution experience in India.
- Authors: Subhashraj K
- Issue date: 2008 Dec
- Salivary gland tumours: 25 years of experience from a single institution in Croatia.
- Authors: Lukšić I, Virag M, Manojlović S, Macan D
- Issue date: 2012 Apr